A Weight Loss RCT Comparing Keyto vs Weight Watchers
- Conditions
- Overweight and ObesityKetogenic Diet
- Interventions
- Other: Weight Watchers appDevice: Keyto device + app
- Registration Number
- NCT04165707
- Lead Sponsor
- University of British Columbia
- Brief Summary
Very low-carbohydrate ketogenic diet may have beneficial metabolic and weight loss effects, however, adhering to this diet may be challenging. Keyto is a self-monitoring and app-enhanced intervention to help individuals learn about and monitor their breath acetone (a measure of ketosis) levels to promote dietary change and weight loss. The purpose of this research is to test the Keyto self-monitoring + app intervention against a "standard of care" weight loss dietary app (Weight Watchers). 144 participants will be recruited through Facebook ads, provide online consent, and will be randomized to one of the two conditions. Weight loss after 12 weeks will be assessed as the primary outcome, with weight loss at 24 and 48 weeks being secondary outcomes. Blood samples will be collected at baseline and 12 weeks with optional blood samples at 48 weeks follow up.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 155
- Age 18-64
- Living in the State of California
- Body mass index (BMI) 27-43
- Must speak, read, and comprehend English
- Access to reliable internet and wi-fi
- Must have a valid email address and phone number
- Must have an Apple iPhone (iPhone 7 or later, iOS 11 or later) with cellular data plan
- Must have a kitchen and be willing to cook
- Willingness to reduce carbohydrate intake to less than 30g/day
- Willingness to restrict intake of added sugar, bread, grain, rice, pasta, sweets, most fruits, pastries, and other carbohydrates
- Willingness to comply with a strict diet for 12 months
- Willingness to eat a diet that is primarily plant and fish-based
- Interest in losing weight
- HIV or immunocompromised
- Current or past cancer diagnosis
- Pregnant, breastfeeding, or planned pregnancy in next 12 months
- Beginning or ending hormonal contraception in next 12 months
- Current diagnosis of diabetes
- History of heart attack or stent
- Currently taking glucose-lowering drugs, statins, or oral steroids
- History of gastric bypass surgery or any other weight-loss surgery
- History of anorexia or bulimia
- History of mental illness
- Current smoker or smoked cigarettes within past 12 months
- Currently eating fewer than 50 g carbohydrates per day
- Have tried a low-carb, high fat (ketogenic diet) within the past 3 months
- Recent weight loss or gain of more than 5% body weight in past 6 months
- Previous experience with the Weight Watchers diet app
- Experience with a low-carbohydrate of ketogenic diet within past 6 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Weight Watchers comparator arm Weight Watchers app Weight Watchers app Keyto intervention arm Keyto device + app Keyto device + app
- Primary Outcome Measures
Name Time Method Change in body mass at 12 weeks 12 weeks from baseline Change in body mass (in kilograms)
- Secondary Outcome Measures
Name Time Method Change in body mass at 24 and 48 weeks 24 and 48 weeks from baseline Change in body mass (in kilograms)
Carbohydrate intake 12, 24, and 48 weeks from baseline Total consumption of carbohydrates in 24 hour period (in grams)
Total fat intake 12, 24, and 48 weeks from baseline Total consumption of fat in 24 hour period (in grams)
Saturated fat intake 12, 24, and 48 weeks from baseline Total consumption of saturated fat in 24 hour period (in grams)
Polyunsaturated fat intake 12, 24, and 48 weeks from baseline Total consumption of polyunsaturated fat in 24 hour period (in grams)
Monounsaturated fat intake 12, 24, and 48 weeks from baseline Total consumption of monounsaturated fat in 24 hour period (in grams)
Total energy intake 12, 24, and 48 weeks from baseline Total energy intake in 24 hour period (in kilocalories)
HbA1C 12 and 48 weeks from baseline Blood test will be used to determine changes in HbA1C
Fasting glucose 12 and 48 weeks from baseline Blood test will be used to determine changes in fasting serum glucose
Fasting insulin 12 and 48 weeks from baseline Blood test will be used to determine changes in fasting serum insulin
Fasting high-sensitivity C-reactive protein 12 and 48 weeks from baseline Blood test will be used to determine changes in fasting serum high-sensitivity C-reactive protein
Fasting homeostasis model assessment of insulin resistance (HOMA-IR) 12 and 48 weeks from baseline Blood test will be used to determine changes in HOMA-IR
Fasting total cholesterol 12 and 48 weeks from baseline Blood test will be used to determine changes in serum total cholesterol
Fasting high-density lipoprotein (HDL) cholesterol 12 and 48 weeks from baseline Blood test will be used to determine changes in serum HDL cholesterol
Fasting lipoprotein fractions 12 and 48 weeks from baseline Blood test will determine changes in serum lipoprotein fractions measured by ion mobility
Fasting lipoprotein (a) 12 and 48 weeks from baseline Blood test will determine changes in serum lipoprotein (a)
Fasting triglycerides 12 and 48 weeks from baseline Blood test will determine changes in serum trigylcerides
Fasting non-HDL cholesterol 12 and 48 weeks from baseline Blood test will determine changes in serum non-HDL cholesterol
Trial Locations
- Locations (1)
University of British Columbia
🇨🇦Kelowna, British Columbia, Canada